Weeks before New Zealand’s medical marijuana regulations take effect, Auckland-based Helius Therapeutics says it has raised 20 million New Zealand dollars ($12.8 million) to help fund facility expansion and clinical trials. Helius is among nearly two-dozen companies that are licensed to grow cannabis for research purposes. After the regulatory foundation for New Zealand’s medical cannabis […]
New Zealand cannabis firm Helius raises NZ$20M for expansion, clinical trials is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs
Read More: New Zealand cannabis firm Helius raises NZM for expansion, clinical trials
Comments are closed, but trackbacks and pingbacks are open.